Schedule V controlled substance (US)
GPTKB entity
Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Controlled substance schedule
|
| gptkbp:criteria |
Currently accepted medical use in treatment in the United States
Low potential for abuse relative to Schedule IV Abuse may lead to limited physical or psychological dependence relative to Schedule IV |
| gptkbp:example |
gptkb:pregabalin
gptkb:lacosamide cough preparations with less than 200 mg codeine per 100 ml ezogabine |
| gptkbp:hasLowerAbusePotentialThan |
gptkb:Schedule_IV_controlled_substance_(US)
|
| https://www.w3.org/2000/01/rdf-schema#label |
Schedule V controlled substance (US)
|
| gptkbp:legalStatus |
Prescription only
|
| gptkbp:partOf |
gptkb:Controlled_Substances_Act_(US)
|
| gptkbp:regulates |
gptkb:Drug_Enforcement_Administration
|
| gptkbp:bfsParent |
gptkb:Schedule_IV_controlled_substance_(US)
|
| gptkbp:bfsLayer |
7
|